The mortality rate for autologous stem cell transplants can differ based on a number of variables that include the patient’s general health, condition treated and specific procedure details. This is why it’s crucial to discuss such issues with a hematologist-oncologist or transplant specialist who can provide personalized details based on the actual medical case. They may present possible data and evaluate the risks-benefits according to separate health condition of this patient or form of treatment for certain illness. It is important to have a broad understanding from an expert in this area.

If the treatment doesn't seem to be working, some diagnostics to keep an eye out for are if your symptoms don't improve or actually get worse, if new symptoms emerge that weren't present earlier, or if you experience side effects from the treatment. These things could be the indications that the specific therapy is not your cup of tea. In such cases, it's crucial to the doctor to discuss other alternative solutions that may suit you better.

If one has missing teeth, I recommend seeking a specialist's consultation, such as a prosthodontist. Despite the potential for stem-cell therapy to provide tooth replacements, it is yet to be confirmed as a proven method. 

Stem cell therapy is helpful for treatment of type 2 diabetes, but it is not yet FDA approved and is under clinical trials. I advise you to consult a doctor in person. Based on proper evaluation , he will suggest whether stem cell therapy is right for you and discuss the treatment options that you can consider for managing your diabetes. I hope this proved useful. Thanks

Spinal infarction or spinal stroke is a disruption of the blood flow to the spinal cord and injury of its tissues. The causes may consist of atherosclerosis, where the arteries are narrowed or blocked because of plaque accumulation, and embolisms when blood clots or other debris travel to spinal arteries leading to reduced blood flow. Other possible causes include vasculitis, arteritis, or disorders of coagulation. .

The disease process of multiple myeloma has several factors that cause elevated erythrocyte sedimentation rate ESR. First of all, abnormal proteins produced by myeloma cells or rather immunoglobulins and their components may cause the increase in blood viscosity which leads to an increased ESR. Myeloma cells can cause inflammation and increase the secretion of some proteins that influence sedimentation rate. The effect of the disease on marrow function, and in particular its overproduction with plasma cells may also impact ESR levels. Elevated levels of the ESR are quite general in pricing an infection and can act as a predictor to determine how much myeloma-related irregularities is presently affecting one’s body. Monitoring of ESR regularly with other clinical parameters helps to evaluate disease progression and the patient’s response to treatment in multiple myeloma.

Yes it is possible. We have good results in development delayed cases. Without seeing reports we can't disclose treatment cost. Kindly ask for reports and schedule call.